Independence Blue Cross has agreed to pay $22.5 million to resolve allegations that it used inaccurate diagnosis codes to inflate its Medicare Advantage payments, confirming the Independence Blue Cross $22.5 million settlement announced in a Sept. 30 Justice Department news release.
The Three Alleged Violations Behind This Independence Blue Cross $22.5 Million Settlement
The government alleged the insurer violated the False Claims Act in three ways for payment years 2017 through 2021. It says the insurer sent CMS diagnosis codes the records didn’t support, didn’t withdraw inflated codes that led to overpayments, and falsely told CMS its data was accurate.
How the Alleged Scheme Operated
The case centers on IBX’s chart review program. Nurse reviewers went through patient medical records to find every supported condition, and IBX used what they found to send CMS more codes and collect more money. When a review didn’t support a code IBX had already reported, the government says the insurer ignored that result instead of deleting the code and paying the money back.
The Whistleblower Behind This Independence Blue Cross $22.5 Million Settlement
A former IBX employee brought the whistleblower suit, United States ex rel. Crawford v. Independence Blue Cross, in the U.S. District Court for the Eastern District of Pennsylvania. The whistleblower will receive $3.825 million.
Why Whistleblower Suits Continue Driving These Cases
This marks another in a growing line of Medicare Advantage risk adjustment settlements originating from whistleblower lawsuits filed by former insurer employees, a pattern seen in several other recent cases involving major national and regional plans, suggesting internal compliance staff remain a significant source of these fraud allegations reaching federal enforcement.
The Justice Department’s Statement on This Independence Blue Cross $22.5 Million Settlement
“When insurers knowingly and improperly retain inflated payments based on inaccurate and untruthful diagnoses, we will hold them accountable whether they are a small regional plan or a large nationwide organization,” said Brett Shumate, assistant attorney general of the Justice Department’s Civil Division. Shumate noted that the government pays private insurers more than $530 billion each year for Medicare Advantage.
Why This Statement Explicitly Targets Regional Plans
Shumate’s specific framing, that enforcement applies “whether they are a small regional plan or a large nationwide organization,” signals the Justice Department intends to pursue these cases regardless of insurer size, extending the kind of risk adjustment scrutiny more commonly associated with large national insurers to regional Blues plans like Independence Blue Cross as well.
Independence Blue Cross’s Response to This $22.5 Million Settlement
In a statement shared with Becker’s, Independence Blue Cross said it “chose to resolve the matter to avoid the delay, uncertainty, expense, and distraction of prolonged litigation.” The insurer added that many major health plans have faced similar government scrutiny regarding Medicare Advantage risk adjustment requirements and practices, reflecting industry-wide challenges in the application of these standards.
IBX’s Characterization of the Underlying Dispute
“This matter was not about the quality of care our members received,” the statement read. “It involved differing views regarding certain documentation and reporting requirements under the Medicare Advantage risk adjustment program.” This framing positions the dispute as a technical disagreement over documentation standards rather than an admission of deliberate wrongdoing, consistent with the settlement resolving allegations without a determination of liability.
How This Fits Independence Blue Cross’s Broader Recent News
This settlement arrives the same week Independence Blue Cross named Christine Kourouklis as CFO and Brian Iaia as general counsel, both drawn from other major payer organizations. The timing means IBX’s incoming legal and financial leadership steps into roles immediately shaped by this resolved enforcement matter.
Why This Timing May Matter for IBX’s New Leadership
With Iaia arriving as general counsel just as this settlement becomes public, and given his prior background in regulatory affairs and transactions at UnitedHealthcare, his early priorities at Independence Blue Cross may include reinforcing the risk adjustment documentation and compliance practices directly implicated in this case.
What This Independence Blue Cross $22.5 Million Settlement Means Going Forward
With the settlement resolving allegations without any determination of liability, Independence Blue Cross avoids the cost and uncertainty of prolonged litigation while still facing a significant financial penalty tied to its Medicare Advantage risk adjustment practices between 2017 and 2021. Given the insurer’s own framing that similar scrutiny has affected many major health plans industrywide, this case adds to a now-familiar pattern of Medicare Advantage coding settlements, including recent OIG findings against UnitedHealthcare in Texas and Wisconsin, suggesting risk adjustment compliance remains a persistent, industry-spanning enforcement priority.
What to Watch Going Forward
As Independence Blue Cross moves past this settlement, industry observers will likely watch whether its newly appointed CFO and general counsel implement specific changes to the chart review and risk adjustment reporting processes central to this case. Given the Justice Department’s explicit statement that enforcement applies regardless of insurer size, this Independence Blue Cross $22.5 million settlement may signal continued federal scrutiny extending beyond the largest national insurers to regional Blues plans and other mid-sized Medicare Advantage organizations across the country.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
